Overview

Ethnic Variations in Antidepressant Response

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

This 11-week study aims to determine how genetic factors affect the way African Americans and Caucasians with major depression respond to antidepressant medication [citalopram (Celexa®)].

Phase:

Phase 4

Details

Lead Sponsor:

National Institute of Mental Health (NIMH)

Treatments:

Antidepressive Agents
Citalopram
Dexetimide